Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Arrest | 95 | 2024 | 1506 | 12.470 |
Why?
|
Cardiopulmonary Resuscitation | 84 | 2024 | 1004 | 11.220 |
Why?
|
Out-of-Hospital Cardiac Arrest | 50 | 2024 | 347 | 10.190 |
Why?
|
Thiamine | 27 | 2024 | 160 | 7.780 |
Why?
|
Lactic Acid | 28 | 2024 | 1134 | 5.920 |
Why?
|
Shock, Septic | 22 | 2024 | 761 | 5.910 |
Why?
|
Hypothermia, Induced | 28 | 2023 | 758 | 4.940 |
Why?
|
Pyruvate Dehydrogenase Complex | 8 | 2024 | 63 | 3.300 |
Why?
|
Vasoconstrictor Agents | 18 | 2022 | 651 | 3.170 |
Why?
|
Sepsis | 28 | 2024 | 2592 | 2.820 |
Why?
|
Ubiquinone | 6 | 2021 | 183 | 2.530 |
Why?
|
Emergency Medical Services | 29 | 2023 | 1925 | 2.520 |
Why?
|
Thiamine Deficiency | 6 | 2024 | 48 | 2.450 |
Why?
|
Epinephrine | 14 | 2021 | 791 | 2.430 |
Why?
|
Cytochromes c | 5 | 2019 | 173 | 1.950 |
Why?
|
Diabetic Ketoacidosis | 5 | 2024 | 257 | 1.830 |
Why?
|
Hospital Mortality | 39 | 2022 | 5425 | 1.680 |
Why?
|
Coma | 6 | 2023 | 487 | 1.560 |
Why?
|
Critical Care | 12 | 2024 | 2699 | 1.520 |
Why?
|
Adrenergic beta-Agonists | 5 | 2016 | 345 | 1.480 |
Why?
|
Neuromuscular Blockade | 3 | 2020 | 146 | 1.460 |
Why?
|
Intensive Care Units | 17 | 2021 | 3736 | 1.460 |
Why?
|
Body Temperature | 8 | 2021 | 777 | 1.360 |
Why?
|
Rewarming | 5 | 2021 | 64 | 1.300 |
Why?
|
Acidosis, Lactic | 6 | 2014 | 145 | 1.180 |
Why?
|
Electric Countershock | 12 | 2019 | 537 | 1.170 |
Why?
|
Severity of Illness Index | 17 | 2021 | 15840 | 1.170 |
Why?
|
Anti-Arrhythmia Agents | 9 | 2020 | 784 | 1.160 |
Why?
|
Respiratory Insufficiency | 9 | 2017 | 1231 | 1.100 |
Why?
|
Respiratory Rate | 4 | 2018 | 175 | 1.090 |
Why?
|
Positive-Pressure Respiration | 4 | 2013 | 636 | 1.080 |
Why?
|
American Heart Association | 13 | 2023 | 1081 | 1.060 |
Why?
|
Community-Acquired Infections | 3 | 2019 | 461 | 1.050 |
Why?
|
Resuscitation | 7 | 2022 | 661 | 1.040 |
Why?
|
Leukocytes, Mononuclear | 4 | 2018 | 1827 | 1.030 |
Why?
|
Vitamin B Complex | 7 | 2024 | 297 | 0.990 |
Why?
|
Emergency Service, Hospital | 29 | 2020 | 7818 | 0.980 |
Why?
|
Oxygen Consumption | 10 | 2024 | 1843 | 0.970 |
Why?
|
Intubation, Intratracheal | 8 | 2019 | 1328 | 0.960 |
Why?
|
Shock | 4 | 2019 | 317 | 0.920 |
Why?
|
Hypotension | 6 | 2021 | 883 | 0.900 |
Why?
|
Pulmonary Embolism | 5 | 2020 | 2543 | 0.880 |
Why?
|
Humans | 239 | 2024 | 760621 | 0.870 |
Why?
|
Middle Aged | 124 | 2024 | 220352 | 0.860 |
Why?
|
Respiration, Artificial | 14 | 2023 | 2622 | 0.850 |
Why?
|
Coronary Artery Bypass | 5 | 2018 | 2272 | 0.850 |
Why?
|
Critical Illness | 8 | 2023 | 2709 | 0.840 |
Why?
|
Male | 154 | 2024 | 359744 | 0.830 |
Why?
|
Aged | 109 | 2024 | 169152 | 0.830 |
Why?
|
Ascorbic Acid | 4 | 2020 | 655 | 0.810 |
Why?
|
Propanolamines | 1 | 2022 | 162 | 0.770 |
Why?
|
Female | 153 | 2024 | 391270 | 0.760 |
Why?
|
Acute Kidney Injury | 5 | 2023 | 1941 | 0.750 |
Why?
|
APACHE | 4 | 2021 | 267 | 0.740 |
Why?
|
Hypothermia | 3 | 2015 | 188 | 0.710 |
Why?
|
Ventricular Fibrillation | 7 | 2020 | 539 | 0.690 |
Why?
|
Adrenergic alpha-Agonists | 3 | 2016 | 178 | 0.680 |
Why?
|
Prone Position | 1 | 2020 | 196 | 0.680 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 144 | 0.670 |
Why?
|
Nervous System Diseases | 6 | 2018 | 1647 | 0.660 |
Why?
|
Registries | 31 | 2022 | 8469 | 0.660 |
Why?
|
Prospective Studies | 48 | 2024 | 54303 | 0.640 |
Why?
|
Alcoholism | 2 | 2021 | 1961 | 0.640 |
Why?
|
Blood Circulation | 4 | 2017 | 249 | 0.630 |
Why?
|
Advanced Cardiac Life Support | 3 | 2020 | 78 | 0.630 |
Why?
|
Influenza, Human | 2 | 2021 | 1528 | 0.620 |
Why?
|
Double-Blind Method | 18 | 2024 | 12427 | 0.620 |
Why?
|
Fluid Therapy | 5 | 2015 | 579 | 0.610 |
Why?
|
Retrospective Studies | 56 | 2022 | 80372 | 0.610 |
Why?
|
Patient Positioning | 1 | 2020 | 327 | 0.600 |
Why?
|
Brain Edema | 2 | 2014 | 603 | 0.600 |
Why?
|
Perioperative Care | 2 | 2015 | 1037 | 0.590 |
Why?
|
Intubation | 2 | 2017 | 139 | 0.580 |
Why?
|
Pneumonia | 3 | 2019 | 2131 | 0.580 |
Why?
|
Wernicke Encephalopathy | 2 | 2007 | 29 | 0.570 |
Why?
|
Creatinine | 3 | 2023 | 1903 | 0.570 |
Why?
|
Hydrocortisone | 5 | 2024 | 1803 | 0.560 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2021 | 622 | 0.560 |
Why?
|
Informed Consent | 1 | 2023 | 1005 | 0.560 |
Why?
|
Vomiting | 2 | 2010 | 650 | 0.550 |
Why?
|
Aged, 80 and over | 45 | 2020 | 58995 | 0.550 |
Why?
|
Practice Guidelines as Topic | 18 | 2019 | 7475 | 0.550 |
Why?
|
Guidelines as Topic | 2 | 2019 | 1392 | 0.530 |
Why?
|
Fever | 3 | 2015 | 1617 | 0.530 |
Why?
|
Marijuana Abuse | 2 | 2010 | 411 | 0.520 |
Why?
|
Pulse | 2 | 2018 | 218 | 0.520 |
Why?
|
Cause of Death | 5 | 2019 | 3725 | 0.490 |
Why?
|
Survival Analysis | 15 | 2020 | 10182 | 0.480 |
Why?
|
Vasopressins | 3 | 2021 | 355 | 0.480 |
Why?
|
Treatment Outcome | 38 | 2024 | 65017 | 0.460 |
Why?
|
Glycolysis | 1 | 2018 | 828 | 0.460 |
Why?
|
Adult | 68 | 2023 | 219994 | 0.460 |
Why?
|
Survival Rate | 20 | 2021 | 12808 | 0.450 |
Why?
|
Wakefulness | 1 | 2020 | 1255 | 0.440 |
Why?
|
Mouth Floor | 1 | 2013 | 38 | 0.440 |
Why?
|
Hemodynamics | 4 | 2022 | 4174 | 0.440 |
Why?
|
Plethysmography, Whole Body | 1 | 2013 | 25 | 0.440 |
Why?
|
Withholding Treatment | 2 | 2019 | 613 | 0.440 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1869 | 0.430 |
Why?
|
Carbon Dioxide | 5 | 2023 | 1146 | 0.430 |
Why?
|
Amiodarone | 5 | 2020 | 218 | 0.420 |
Why?
|
Ventricular Function | 1 | 2014 | 408 | 0.420 |
Why?
|
Survivors | 9 | 2023 | 2375 | 0.410 |
Why?
|
Time Factors | 21 | 2020 | 40165 | 0.410 |
Why?
|
Consensus | 12 | 2023 | 3113 | 0.400 |
Why?
|
Micronutrients | 1 | 2015 | 381 | 0.400 |
Why?
|
Lung Volume Measurements | 1 | 2013 | 376 | 0.390 |
Why?
|
Prognosis | 23 | 2021 | 29658 | 0.390 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 1166 | 0.390 |
Why?
|
Bacteremia | 4 | 2012 | 980 | 0.390 |
Why?
|
Hospitalization | 15 | 2021 | 10790 | 0.390 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 858 | 0.380 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 319 | 0.380 |
Why?
|
Airway Management | 4 | 2019 | 310 | 0.380 |
Why?
|
Predictive Value of Tests | 16 | 2018 | 15289 | 0.380 |
Why?
|
Cardiology | 5 | 2020 | 1723 | 0.380 |
Why?
|
Logistic Models | 17 | 2019 | 13314 | 0.370 |
Why?
|
Patient Discharge | 14 | 2021 | 3476 | 0.370 |
Why?
|
Myoclonus | 1 | 2011 | 107 | 0.370 |
Why?
|
Emergencies | 4 | 2020 | 1211 | 0.370 |
Why?
|
ROC Curve | 7 | 2018 | 3568 | 0.360 |
Why?
|
Lactates | 3 | 2023 | 404 | 0.360 |
Why?
|
Regional Health Planning | 1 | 2011 | 96 | 0.360 |
Why?
|
Kidney | 4 | 2024 | 7064 | 0.360 |
Why?
|
Acid-Base Imbalance | 2 | 2009 | 41 | 0.360 |
Why?
|
United States | 37 | 2022 | 72461 | 0.350 |
Why?
|
Nausea | 2 | 2010 | 678 | 0.340 |
Why?
|
Vitamins | 3 | 2014 | 1634 | 0.340 |
Why?
|
Defibrillators | 3 | 2020 | 40 | 0.340 |
Why?
|
Pilot Projects | 7 | 2017 | 8555 | 0.340 |
Why?
|
Critical Pathways | 1 | 2013 | 475 | 0.340 |
Why?
|
Length of Stay | 2 | 2015 | 6479 | 0.340 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 961 | 0.330 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.320 |
Why?
|
Acute Disease | 8 | 2024 | 7269 | 0.320 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1266 | 0.320 |
Why?
|
Microcirculation | 1 | 2013 | 1278 | 0.310 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1572 | 0.310 |
Why?
|
Angiography | 1 | 2013 | 1605 | 0.300 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 814 | 0.300 |
Why?
|
Biomedical Research | 1 | 2023 | 3426 | 0.300 |
Why?
|
Models, Organizational | 1 | 2011 | 545 | 0.290 |
Why?
|
Postoperative Complications | 4 | 2016 | 15697 | 0.290 |
Why?
|
Central Venous Pressure | 1 | 2007 | 79 | 0.290 |
Why?
|
Marijuana Smoking | 1 | 2010 | 257 | 0.290 |
Why?
|
Cannabinoids | 1 | 2009 | 173 | 0.280 |
Why?
|
Rhabdomyolysis | 1 | 2007 | 155 | 0.270 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5889 | 0.270 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 1717 | 0.270 |
Why?
|
Hospitals, Urban | 5 | 2012 | 499 | 0.270 |
Why?
|
Emergency Treatment | 6 | 2023 | 498 | 0.270 |
Why?
|
Leukocyte Count | 1 | 2010 | 1600 | 0.270 |
Why?
|
Monitoring, Physiologic | 5 | 2019 | 1784 | 0.270 |
Why?
|
Blood Specimen Collection | 1 | 2007 | 238 | 0.260 |
Why?
|
Lidocaine | 5 | 2020 | 538 | 0.260 |
Why?
|
Beriberi | 1 | 2004 | 6 | 0.250 |
Why?
|
Oxygen | 3 | 2018 | 4193 | 0.250 |
Why?
|
Cardiovascular Agents | 3 | 2021 | 867 | 0.250 |
Why?
|
Advisory Committees | 4 | 2018 | 788 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2024 | 10344 | 0.240 |
Why?
|
Atropine | 3 | 2020 | 245 | 0.240 |
Why?
|
Pulmonary Artery | 1 | 2013 | 1921 | 0.240 |
Why?
|
Recovery of Function | 4 | 2018 | 2985 | 0.240 |
Why?
|
Cohort Studies | 19 | 2020 | 41335 | 0.240 |
Why?
|
Cannabis | 1 | 2010 | 436 | 0.230 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 844 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 7 | 2014 | 20509 | 0.230 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 7408 | 0.230 |
Why?
|
Mitochondria | 1 | 2017 | 3600 | 0.220 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2234 | 0.220 |
Why?
|
Calcitriol | 2 | 2014 | 297 | 0.210 |
Why?
|
Dog Diseases | 1 | 2023 | 141 | 0.210 |
Why?
|
Tidal Volume | 2 | 2017 | 487 | 0.210 |
Why?
|
Blood Gas Analysis | 4 | 2018 | 379 | 0.210 |
Why?
|
Risk Assessment | 9 | 2018 | 24123 | 0.210 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1032 | 0.200 |
Why?
|
Patient Care Team | 1 | 2013 | 2511 | 0.200 |
Why?
|
Cytokines | 3 | 2016 | 7343 | 0.200 |
Why?
|
Multiple Organ Failure | 3 | 2020 | 386 | 0.190 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2015 | 3334 | 0.190 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2733 | 0.190 |
Why?
|
Glucocorticoids | 2 | 2021 | 2145 | 0.190 |
Why?
|
Magnesium | 3 | 2019 | 810 | 0.190 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39261 | 0.190 |
Why?
|
Hospitals | 8 | 2022 | 3928 | 0.190 |
Why?
|
Guideline Adherence | 4 | 2019 | 2283 | 0.180 |
Why?
|
Area Under Curve | 7 | 2018 | 1636 | 0.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 691 | 0.180 |
Why?
|
Pregnancy Complications, Cardiovascular | 3 | 2015 | 516 | 0.180 |
Why?
|
Stroke Volume | 1 | 2014 | 5523 | 0.180 |
Why?
|
Interleukins | 2 | 2016 | 785 | 0.180 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2852 | 0.180 |
Why?
|
Tachycardia, Ventricular | 3 | 2018 | 1303 | 0.180 |
Why?
|
Methylprednisolone | 1 | 2021 | 384 | 0.170 |
Why?
|
Troponin I | 1 | 2004 | 638 | 0.170 |
Why?
|
Triage | 4 | 2009 | 987 | 0.170 |
Why?
|
Internationality | 2 | 2015 | 1004 | 0.170 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2477 | 0.170 |
Why?
|
Young Adult | 12 | 2022 | 58741 | 0.170 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 3620 | 0.170 |
Why?
|
Glasgow Coma Scale | 3 | 2017 | 579 | 0.170 |
Why?
|
Tachycardia | 1 | 2022 | 602 | 0.170 |
Why?
|
Adolescent | 18 | 2021 | 87810 | 0.170 |
Why?
|
Hospitals, Pediatric | 5 | 2022 | 1854 | 0.170 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2015 | 352 | 0.170 |
Why?
|
Norepinephrine | 1 | 2022 | 900 | 0.170 |
Why?
|
Comorbidity | 7 | 2017 | 10551 | 0.160 |
Why?
|
Life Support Care | 1 | 2020 | 222 | 0.160 |
Why?
|
Receptors, Purinergic P2X1 | 1 | 2018 | 8 | 0.160 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2019 | 87 | 0.160 |
Why?
|
Inflammation | 4 | 2024 | 10756 | 0.160 |
Why?
|
Organizational Case Studies | 1 | 2019 | 301 | 0.160 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1722 | 0.160 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14660 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 242 | 0.160 |
Why?
|
Odds Ratio | 9 | 2019 | 9716 | 0.160 |
Why?
|
Residence Characteristics | 2 | 2019 | 2062 | 0.160 |
Why?
|
First Aid | 3 | 2023 | 67 | 0.160 |
Why?
|
Anaerobiosis | 1 | 2018 | 139 | 0.150 |
Why?
|
Child | 20 | 2023 | 79806 | 0.150 |
Why?
|
Heart Failure | 2 | 2019 | 11847 | 0.150 |
Why?
|
Vital Signs | 2 | 2017 | 144 | 0.150 |
Why?
|
Brain Ischemia | 1 | 2011 | 3127 | 0.150 |
Why?
|
Mitochondria, Heart | 1 | 2019 | 229 | 0.150 |
Why?
|
Quality of Health Care | 3 | 2013 | 4360 | 0.150 |
Why?
|
Ribonuclease P | 1 | 2017 | 17 | 0.140 |
Why?
|
Benzoates | 1 | 2019 | 212 | 0.140 |
Why?
|
Uremia | 1 | 2018 | 201 | 0.140 |
Why?
|
Hypercapnia | 1 | 2018 | 261 | 0.140 |
Why?
|
Calcitonin | 1 | 2018 | 330 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2017 | 22053 | 0.140 |
Why?
|
Hematocrit | 1 | 2018 | 629 | 0.140 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2942 | 0.140 |
Why?
|
Hyperthermia, Induced | 2 | 2019 | 417 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1100 | 0.140 |
Why?
|
Personnel Turnover | 1 | 2017 | 86 | 0.140 |
Why?
|
Inpatients | 3 | 2019 | 2581 | 0.130 |
Why?
|
Balloon Occlusion | 1 | 2017 | 127 | 0.130 |
Why?
|
Infant, Newborn | 10 | 2023 | 26181 | 0.130 |
Why?
|
Pyrimidinones | 1 | 2019 | 384 | 0.130 |
Why?
|
Pulmonary Gas Exchange | 1 | 2018 | 378 | 0.130 |
Why?
|
Near Drowning | 1 | 2015 | 11 | 0.130 |
Why?
|
Confusion | 1 | 2018 | 279 | 0.130 |
Why?
|
Catheterization, Central Venous | 2 | 2015 | 526 | 0.130 |
Why?
|
Culture Media | 1 | 2018 | 900 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2004 | 1190 | 0.130 |
Why?
|
Protective Agents | 1 | 2017 | 150 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2016 | 3484 | 0.130 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 188 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6498 | 0.130 |
Why?
|
Hyperoxia | 1 | 2018 | 250 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2017 | 235 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 717 | 0.130 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2018 | 1459 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2018 | 621 | 0.130 |
Why?
|
Prevalence | 6 | 2023 | 15687 | 0.130 |
Why?
|
Infant | 12 | 2020 | 36060 | 0.130 |
Why?
|
Blood Pressure | 3 | 2019 | 8525 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2015 | 404 | 0.130 |
Why?
|
Injections, Intravenous | 2 | 2014 | 1385 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 209 | 0.130 |
Why?
|
Risk Factors | 15 | 2020 | 74359 | 0.120 |
Why?
|
Hyperglycemia | 3 | 2021 | 1380 | 0.120 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 208 | 0.120 |
Why?
|
Child, Preschool | 12 | 2020 | 42063 | 0.120 |
Why?
|
Medical Futility | 1 | 2016 | 133 | 0.120 |
Why?
|
Propensity Score | 6 | 2019 | 1928 | 0.120 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2015 | 109 | 0.120 |
Why?
|
Quality Improvement | 4 | 2019 | 3836 | 0.120 |
Why?
|
Disease Management | 2 | 2015 | 2514 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4357 | 0.120 |
Why?
|
Bacterial Infections | 2 | 2020 | 1403 | 0.120 |
Why?
|
Hospitals, University | 3 | 2012 | 568 | 0.120 |
Why?
|
Cardiac Tamponade | 1 | 2015 | 174 | 0.120 |
Why?
|
Angiopoietin-2 | 1 | 2015 | 172 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10827 | 0.120 |
Why?
|
Incidence | 5 | 2019 | 21392 | 0.120 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 48 | 0.110 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 34 | 0.110 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12159 | 0.110 |
Why?
|
Emergency Medicine | 4 | 2007 | 1196 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2019 | 2141 | 0.110 |
Why?
|
PubMed | 1 | 2013 | 128 | 0.110 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5325 | 0.110 |
Why?
|
Naloxone | 1 | 2015 | 369 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 352 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2023 | 11891 | 0.100 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2015 | 314 | 0.100 |
Why?
|
Renal Dialysis | 2 | 2017 | 1801 | 0.100 |
Why?
|
Patients | 1 | 2019 | 906 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1091 | 0.100 |
Why?
|
Hot Temperature | 1 | 2018 | 1435 | 0.100 |
Why?
|
Viral Load | 1 | 2021 | 3322 | 0.100 |
Why?
|
Confidence Intervals | 2 | 2021 | 2932 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 2471 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18137 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1826 | 0.100 |
Why?
|
Arctic Regions | 1 | 2011 | 25 | 0.090 |
Why?
|
Dentures | 1 | 2010 | 12 | 0.090 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 161 | 0.090 |
Why?
|
Resuscitation Orders | 1 | 2013 | 270 | 0.090 |
Why?
|
Treatment Failure | 2 | 2020 | 2648 | 0.090 |
Why?
|
Partial Pressure | 3 | 2018 | 245 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8624 | 0.090 |
Why?
|
Baths | 1 | 2010 | 53 | 0.090 |
Why?
|
Massachusetts | 4 | 2019 | 8803 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 1007 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2362 | 0.090 |
Why?
|
Apyrase | 1 | 2013 | 373 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3839 | 0.090 |
Why?
|
Dogs | 2 | 2023 | 3841 | 0.090 |
Why?
|
Cross Infection | 2 | 2020 | 1434 | 0.090 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2010 | 138 | 0.090 |
Why?
|
Coronary Disease | 1 | 2004 | 5990 | 0.080 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1131 | 0.080 |
Why?
|
Pulmonary Edema | 1 | 2012 | 409 | 0.080 |
Why?
|
Vertigo | 1 | 2011 | 202 | 0.080 |
Why?
|
Data Collection | 3 | 2019 | 3315 | 0.080 |
Why?
|
Urban Health Services | 1 | 2010 | 177 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2016 | 1889 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 367 | 0.080 |
Why?
|
Facial Injuries | 1 | 2010 | 190 | 0.080 |
Why?
|
Qualitative Research | 1 | 2019 | 2963 | 0.080 |
Why?
|
Risk | 3 | 2016 | 9631 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2021 | 3392 | 0.080 |
Why?
|
Calibration | 1 | 2011 | 816 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2255 | 0.080 |
Why?
|
Anaphylaxis | 1 | 2015 | 755 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5797 | 0.080 |
Why?
|
Body Temperature Regulation | 2 | 2021 | 286 | 0.080 |
Why?
|
Observation | 1 | 2010 | 312 | 0.080 |
Why?
|
Coronary Angiography | 2 | 2017 | 4563 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1612 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 22023 | 0.070 |
Why?
|
Delirium | 1 | 2019 | 1663 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2015 | 1398 | 0.070 |
Why?
|
Hypovolemia | 1 | 2007 | 48 | 0.070 |
Why?
|
Glucose | 2 | 2019 | 4351 | 0.070 |
Why?
|
Linear Models | 2 | 2015 | 5877 | 0.070 |
Why?
|
Algorithms | 2 | 2015 | 13981 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12531 | 0.070 |
Why?
|
Patient Transfer | 1 | 2013 | 779 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2010 | 397 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3061 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2924 | 0.070 |
Why?
|
Patient Preference | 1 | 2013 | 922 | 0.060 |
Why?
|
Anti-Asthmatic Agents | 1 | 2010 | 565 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4393 | 0.060 |
Why?
|
Shock, Hemorrhagic | 1 | 2007 | 223 | 0.060 |
Why?
|
Adrenal Insufficiency | 1 | 2007 | 192 | 0.060 |
Why?
|
New Jersey | 1 | 2005 | 291 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4283 | 0.060 |
Why?
|
Heart Rate | 2 | 2014 | 4179 | 0.060 |
Why?
|
Glycoproteins | 1 | 2013 | 2208 | 0.060 |
Why?
|
Physical Exertion | 1 | 2007 | 662 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2010 | 700 | 0.060 |
Why?
|
Animals | 10 | 2023 | 167963 | 0.060 |
Why?
|
Wounds, Gunshot | 1 | 2010 | 581 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4925 | 0.060 |
Why?
|
Pregnancy | 4 | 2015 | 29749 | 0.060 |
Why?
|
Asthma | 3 | 2012 | 6172 | 0.060 |
Why?
|
Thiamine Pyrophosphate | 1 | 2023 | 8 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2029 | 0.060 |
Why?
|
Gram-Negative Bacteria | 2 | 2018 | 272 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2782 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 8035 | 0.060 |
Why?
|
Age Factors | 3 | 2016 | 18416 | 0.060 |
Why?
|
Hippocampus | 1 | 2016 | 3738 | 0.050 |
Why?
|
Liver Diseases | 1 | 2012 | 1302 | 0.050 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2023 | 127 | 0.050 |
Why?
|
Syncope | 1 | 2006 | 428 | 0.050 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 793 | 0.050 |
Why?
|
Cardiac Output | 1 | 2005 | 838 | 0.050 |
Why?
|
Cocaine | 1 | 2007 | 961 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10446 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4000 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9467 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8515 | 0.050 |
Why?
|
Boston | 3 | 2020 | 9280 | 0.050 |
Why?
|
Age Distribution | 2 | 2019 | 2893 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2420 | 0.050 |
Why?
|
Peptides | 1 | 2013 | 4354 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3448 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1204 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2007 | 2435 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2023 | 1544 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5761 | 0.040 |
Why?
|
Head | 1 | 2006 | 922 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13502 | 0.040 |
Why?
|
Denmark | 1 | 2021 | 760 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2019 | 182 | 0.040 |
Why?
|
Mice | 5 | 2019 | 81208 | 0.040 |
Why?
|
Hyponatremia | 1 | 2021 | 279 | 0.040 |
Why?
|
Respiratory Function Tests | 2 | 2018 | 1683 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8552 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2010 | 2890 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20080 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2021 | 916 | 0.040 |
Why?
|
Early Diagnosis | 2 | 2017 | 1180 | 0.040 |
Why?
|
Syndrome | 1 | 2004 | 3280 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2018 | 169 | 0.040 |
Why?
|
Bicarbonates | 1 | 2019 | 292 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2019 | 630 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2010 | 3726 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3224 | 0.040 |
Why?
|
Gram-Positive Bacteria | 1 | 2018 | 178 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 6180 | 0.040 |
Why?
|
Stroke | 3 | 2019 | 9962 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 507 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1668 | 0.040 |
Why?
|
Regression Analysis | 2 | 2017 | 6360 | 0.040 |
Why?
|
Acidosis | 1 | 2018 | 268 | 0.030 |
Why?
|
Temperature | 1 | 2023 | 2221 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 754 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 555 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4412 | 0.030 |
Why?
|
Heart Massage | 1 | 2015 | 31 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 287 | 0.030 |
Why?
|
Hospital Units | 1 | 2016 | 142 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 2017 | 177 | 0.030 |
Why?
|
Telemetry | 1 | 2016 | 199 | 0.030 |
Why?
|
Pennsylvania | 1 | 2016 | 615 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3701 | 0.030 |
Why?
|
Systems Analysis | 1 | 2015 | 169 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 2015 | 267 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2002 | 1399 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15757 | 0.030 |
Why?
|
Cathelicidins | 1 | 2014 | 81 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 351 | 0.030 |
Why?
|
Hospitalists | 1 | 2018 | 295 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1407 | 0.030 |
Why?
|
Child, Hospitalized | 1 | 2015 | 182 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2018 | 3562 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1004 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12965 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 566 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.030 |
Why?
|
Judgment | 1 | 2015 | 273 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2015 | 232 | 0.030 |
Why?
|
Electrocardiography | 2 | 2017 | 6414 | 0.030 |
Why?
|
Obesity | 2 | 2012 | 12922 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2019 | 1577 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1433 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5899 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2222 | 0.030 |
Why?
|
Hypoxia, Brain | 1 | 2013 | 138 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2018 | 931 | 0.030 |
Why?
|
Public-Private Sector Partnerships | 1 | 2013 | 122 | 0.030 |
Why?
|
Tissue and Organ Harvesting | 1 | 2015 | 377 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2014 | 354 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2017 | 1096 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2017 | 894 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3804 | 0.020 |
Why?
|
Dyspnea | 1 | 2019 | 1352 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1386 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 652 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 1014 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21025 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1724 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1588 | 0.020 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2012 | 238 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 385 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 698 | 0.020 |
Why?
|
Respiratory Aspiration | 1 | 2010 | 89 | 0.020 |
Why?
|
Acetaminophen | 1 | 2013 | 553 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3696 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4538 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8313 | 0.020 |
Why?
|
Cosyntropin | 1 | 2007 | 34 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 944 | 0.020 |
Why?
|
Population Surveillance | 1 | 2018 | 2608 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2010 | 1033 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1881 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2754 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4899 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 1832 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2061 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2015 | 1879 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5725 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 694 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2176 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4433 | 0.020 |
Why?
|
Urea | 1 | 2007 | 446 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2007 | 1628 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8482 | 0.010 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2005 | 87 | 0.010 |
Why?
|
Vitamin D | 1 | 2018 | 3291 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5508 | 0.010 |
Why?
|
Forecasting | 1 | 2013 | 2932 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4081 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4035 | 0.010 |
Why?
|
Hormones | 1 | 2007 | 867 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14372 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2007 | 640 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2315 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1407 | 0.010 |
Why?
|
Seizures | 1 | 2015 | 2917 | 0.010 |
Why?
|
Models, Statistical | 1 | 2017 | 5075 | 0.010 |
Why?
|
Perfusion | 1 | 2007 | 1376 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3047 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23711 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1378 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2475 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2012 | 2907 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6381 | 0.010 |
Why?
|
Causality | 1 | 2007 | 1242 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16546 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3387 | 0.010 |
Why?
|
Decision Making | 1 | 2013 | 3925 | 0.010 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5201 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7509 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5870 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6544 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25942 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36290 | 0.000 |
Why?
|